Edoxaban or standard therapy with warfarin for stroke prevention in patients with atrial fibrillation?
Harvard Medical School, MA 02115, USA.
Anna
A
Plitt
Robert P
RP
Giugliano
D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000150:complications*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D065427:Factor Xa Inhibitors / Q000627:therapeutic use*; D006801:Humans; D011725:Pyridines / Q000627:therapeutic use*; D020521:Stroke / Q000209:etiology / Q000517:prevention & control*; D013844:Thiazoles / Q000627:therapeutic use*; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D011725:Pyridines; D013844:Thiazoles; D014859:Warfarin; C552171:edoxaban